Insights on Prior Authorization in Insurance: Navigating New CMS Rules
Newly released federal data analyzed by KFF reveals significant differences in how insurers handle prior authorization requests across Medicare Advantage, Medicaid, and ACA marketplaces. This comes alongside CMS's recent rule update that aims to streamline these procedures and expand transparency requirements for various insurers.
The Centers for Medicare & Medicaid Services (CMS) finalized a rule in 2024 to enhance efficiency in managing prior authorizations, a process insurers use to control healthcare costs by requiring treatments to be pre-approved. Despite improvements, healthcare providers continue to criticize the practice, citing delays in treatment and increased administrative workload. Under the new regulation, Medicare Advantage, Medicaid MCOs, and ACA marketplace insurers must adhere to more robust data reporting mandates. This change reflects growing governmental and legislative scrutiny of prior authorization policies, widely considered a barrier to timely patient care.
Implications of Increased Transparency
The movement towards greater transparency in prior authorization aligns with the broader call for healthcare accessibility and efficiency. Historically, major insurers have simplified their policies, with a reduction in prior authorizations by 11% as of April. Nonetheless, the analysis indicates concern regarding the overall denial rates and the burden on healthcare providers and patients.
Denial Rates and Insurance Variations
KFF's 2025 study, which focused on 14 top-enrolled insurers, highlighted average denial rates of 12% for Medicare Advantage, 14% for Medicaid MCOs, and 18% in ACA markets. The variations between insurers are notable, with significant disparities between companies like Elevance and UnitedHealth within Medicare Advantage plans. Though denial rates for expedited requests are lower, the overall burden remains critical as many denials are eventually overturned but may discourage beneficiaries from appealing.
| Insurance Program | Denial Rate | Appeals Approval Rate |
|---|---|---|
| Medicare Advantage | 12% | 66% |
| Medicaid MCOs | 14% | 50% |
| ACA Marketplaces | 18% | 43% |
Challenges in Data Transparency and Future Directions
The KFF identified limitations in the reported data, primarily due to lack of total request figures and inconsistent reporting formats. Without detailed breakdowns by service type, stakeholders cannot fully assess the frequency of denials for specific care types. As these data transparency initiatives continue to evolve, insurance professionals should closely monitor updates to improve strategic planning and regulatory compliance. The high overturn rates in appeals suggest room for improvement in initial authorization decisions, which may drive further reforms and adjustments within the industry to benefit policyholders and providers alike.